8-K current report · filed Nov 16, 2026

agilon health, inc. (AGL) 8-K Current Report: November 16, 2026

Item 7.01Item EX-99.1AGL overview

Short answer

agilon health, inc. (AGL) filed an 8-K current report with the SEC on November 16, 2026 reporting Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Virtual investor event scheduled for November 17, 2026 at 2:00 PM Eastern.

agilon health, inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 7.01 · Regulation FD Disclosure

  • Virtual investor event scheduled for November 17, 2026 at 2:00 PM Eastern
  • Presentation webcast available through agilon health’s investor relations website
  • Investor presentation furnished as Exhibit 99.1, with replay available after the event

Item EX-99.1 · Exhibit EX-99.1

  • Investor presentation outlines agilon’s technology-enabled Total Care Model, emphasizing clinical pathways, physician engagement and quality programs
  • Platform scale: ~30 markets, ~2,200 primary care physicians, 500K+ Medicare patients and ~$6B managed medical expense as of December 31, 2025
  • Technology infrastructure includes 200M+ clinical documents, 700M+ lab results, 150M+ claims, 65+ payor connections and 120+ EMR integrations through September 17, 2026
  • Clinical pathways target heart failure, dementia, serious illness care and other chronic conditions to reduce avoidable utilization and improve quality outcomes
  • Presentation highlights execution and scalability, but also exposes investors to technology, clinical, reimbursement, leadership-transition and medical-cost risks

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other agilon health, inc. 8-K filings

Get the next AGL 8-K as it lands

Follow AGL for push alerts, or ask the research agent what this filing means.